Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Interest Coverage Ratio (2016 - 2025)

Amicus Therapeutics' Interest Coverage Ratio history spans 16 years, with the latest figure at 1.4 for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 4.47% year-over-year to 1.4, compared with a TTM value of 0.71 through Dec 2025, up 41.63%, and an annual FY2025 reading of 0.71, up 41.63% over the prior year.
  • Interest Coverage Ratio for Q4 2025 was 1.4 at Amicus Therapeutics, down from 2.93 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 2.93 in Q3 2025, with the low at 9.25 in Q1 2022.
  • Average Interest Coverage Ratio over 5 years is 2.54, with a median of 1.87 recorded in 2024.
  • Year-over-year, Interest Coverage Ratio soared 564.02% in 2024 and then crashed 168.48% in 2025.
  • Tracing FOLD's Interest Coverage Ratio over 5 years: stood at 8.84 in 2021, then surged by 56.83% to 3.82 in 2022, then surged by 92.46% to 0.29 in 2023, then soared by 564.02% to 1.34 in 2024, then rose by 4.47% to 1.4 in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Interest Coverage Ratio are 1.4 (Q4 2025), 2.93 (Q3 2025), and 0.82 (Q2 2025).